{"data":[{"accessionNo":"0001172661-26-001229","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":439657,"percentOfClass":4.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001172661-26-001229","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":439657,"percentOfClass":4.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001315863-26-000100","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-01-22","reportingPerson":"Affinity Asset Advisors, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":884172,"percentOfClass":5.5,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001315863-26-000100","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-01-22","reportingPerson":"Michael Cho","reportingCik":null,"personType":"IN,HC","sharesOwned":884172,"percentOfClass":5.5,"filedAt":"2026-01-29","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0000902664-25-005417","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-26","reportingPerson":"Caligan Partners LP","reportingCik":"0001727492","personType":"IA,PN","sharesOwned":6503054,"percentOfClass":9.99,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0000902664-25-005417","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-26","reportingPerson":"David Johnson","reportingCik":"0001785557","personType":"IN,HC","sharesOwned":6503054,"percentOfClass":9.99,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001011438-25-000591","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-25","reportingPerson":"Affinity Healthcare Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":884172,"percentOfClass":5.47,"filedAt":"2025-12-03","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001011438-25-000591","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-25","reportingPerson":"Affinity Asset Advisors, LLC","reportingCik":null,"personType":"IA","sharesOwned":884172,"percentOfClass":5.47,"filedAt":"2025-12-03","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001494695-25-000006","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-25","reportingPerson":"Paul B Manning","reportingCik":"0001494695","personType":"IV","sharesOwned":8056031,"percentOfClass":49.9,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001494695-25-000006","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-25","reportingPerson":"BKB Growth Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":3348372,"percentOfClass":20.9,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001494695-25-000006","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-11-25","reportingPerson":"PBM Capital Investments, LLC","reportingCik":null,"personType":"OO","sharesOwned":25663,"percentOfClass":0.2,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0000902664-25-005145","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-23","reportingPerson":"Caligan Partners LP","reportingCik":"0001727492","personType":"IA,PN","sharesOwned":6503054,"percentOfClass":9.99,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0000902664-25-005145","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-23","reportingPerson":"David Johnson","reportingCik":"0001785557","personType":"IN,HC","sharesOwned":6503054,"percentOfClass":9.99,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001172661-25-005162","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":639193,"percentOfClass":6.77,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"},{"accessionNo":"0001172661-25-005162","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001660334","issuerName":"Verrica Pharmaceuticals Inc.","ticker":"VRCA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":639193,"percentOfClass":6.77,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/vrca"}],"updatedAt":"2026-11-04T07:11:55.406Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/vrca","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}